Apellis Pharmaceuticals Inc (APLS)
49.93
+1.21
(+2.48%)
USD |
NASDAQ |
Apr 24, 16:00
49.95
+0.02
(+0.04%)
Pre-Market: 08:20
Apellis Pharmaceuticals 1 Year Total Returns (Daily): -43.75% for April 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 24, 2024 | -43.75% |
April 23, 2024 | -43.51% |
April 22, 2024 | -44.77% |
April 19, 2024 | -42.11% |
April 18, 2024 | -42.17% |
April 17, 2024 | -41.46% |
April 16, 2024 | -35.99% |
April 15, 2024 | -36.38% |
April 12, 2024 | -35.02% |
April 11, 2024 | -30.03% |
April 10, 2024 | -27.95% |
April 09, 2024 | -30.03% |
April 08, 2024 | -31.70% |
April 05, 2024 | -27.69% |
April 04, 2024 | -28.18% |
April 03, 2024 | -25.73% |
April 02, 2024 | -15.55% |
April 01, 2024 | -9.48% |
March 28, 2024 | -9.54% |
March 27, 2024 | -10.92% |
March 26, 2024 | -6.39% |
March 25, 2024 | -11.90% |
March 22, 2024 | -9.51% |
March 21, 2024 | -8.84% |
March 20, 2024 | -11.94% |
Date | Value |
---|---|
March 19, 2024 | -9.68% |
March 18, 2024 | -10.73% |
March 15, 2024 | -13.41% |
March 14, 2024 | -13.33% |
March 13, 2024 | -8.46% |
March 12, 2024 | -5.98% |
March 11, 2024 | -2.46% |
March 08, 2024 | -4.85% |
March 07, 2024 | -2.45% |
March 06, 2024 | -5.24% |
March 05, 2024 | -3.86% |
March 04, 2024 | -0.54% |
March 01, 2024 | -0.17% |
February 29, 2024 | -5.36% |
February 28, 2024 | -2.18% |
February 27, 2024 | 6.43% |
February 26, 2024 | 7.56% |
February 23, 2024 | 2.26% |
February 22, 2024 | 2.69% |
February 21, 2024 | 14.34% |
February 20, 2024 | 22.27% |
February 16, 2024 | 32.50% |
February 15, 2024 | 27.61% |
February 14, 2024 | 30.37% |
February 13, 2024 | 27.47% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.66%
Minimum
Aug 07 2023
230.1%
Maximum
Jan 23 2020
35.59%
Average
25.24%
Median
Sep 30 2020
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | -1.92% |
Blueprint Medicines Corp | 92.01% |
Alnylam Pharmaceuticals Inc | -29.78% |
Ionis Pharmaceuticals Inc | 18.84% |
Madrigal Pharmaceuticals Inc | -33.09% |